rasvamaksasta

Rasvamaksa, also known as fatty liver disease, is a condition characterized by the accumulation of excess fat in the liver. This is a common condition that can affect anyone, but it is more prevalent in individuals who are overweight or obese, have type 2 diabetes, high cholesterol, or high blood pressure. There are two main types of fatty liver disease: non-alcoholic fatty liver disease (NAFLD) and alcoholic fatty liver disease (AFLD). AFLD is caused by excessive alcohol consumption, while NAFLD is not directly linked to alcohol.

NAFLD exists on a spectrum. The simplest form, simple fatty liver, involves fat in the liver but little to no inflammation or liver cell damage. This form usually doesn't cause significant problems. However, a more advanced form, non-alcoholic steatohepatitis (NASH), involves inflammation and liver cell damage, which can lead to fibrosis (scarring) and eventually cirrhosis or liver cancer.

Symptoms of fatty liver disease are often absent, especially in the early stages. If symptoms do occur, they can include fatigue, weakness, and discomfort in the upper right abdomen. Diagnosis typically involves blood tests to check liver enzymes, imaging studies like ultrasound or CT scans, and sometimes a liver biopsy for a definitive assessment of inflammation and damage.

Treatment for fatty liver disease focuses on addressing the underlying causes. For NAFLD, lifestyle modifications such as weight loss, a healthy diet, regular exercise, and managing conditions like diabetes and high cholesterol are crucial. For AFLD, abstaining from alcohol is the primary treatment. In advanced cases with significant liver damage, further medical interventions may be necessary.